Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac sodium gel in hand osteoarthritis
NCT00171652Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2005
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Diclofenac Gel with Placebo Gel (2 arms). Primary endpoints: Osteoarthritis pain intensity in target hand at 6 weeks, Total Australian/Canadian Osteoarthritis Hand Index score in target hand at 6 weeks and 1 more. Started May 2005; status: completed.
02
Drugs
diclofenac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00171652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171652.